Please take 10 minutes to complete this survey to help us put myeloma on New Zealand’s health agenda and help you to have the best lives possible....
Day: 24 August 2018
Pediatric Guidelines for CAR T-Cell Therapy Help Nurses Recognize AEs Earlier
A year after the first CAR T-cell therapy was approved to treat pediatric patients with relapsed and/or refractory CD19-positive acute lymphoblastic...
Elotuzumab Triplet Granted Priority Review by FDA for Myeloma
A supplemental biologics license application (sBLA) for elotuzumab (Empliciti)Â has been granted a priority review by the FDAÂ for use in combination...